Literature DB >> 15073170

p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.

Jan Bohuslav1, Lin-Feng Chen, Hakju Kwon, Yajun Mu, Warner C Greene.   

Abstract

Apoptosis induced by p53 has been proposed to involve activation of the transcription factor NF-kappaB. Here we describe the novel molecular mechanism through which p53 and DNA-damaging agents activate NF-kappaB. NF-kappaB induction by p53 does not occur through classical activation of the IkappaB kinases and degradation of IkappaBalpha. Rather, p53 expression stimulates the serine/threonine kinase ribosomal S6 kinase 1 (RSK1), which in turn phosphorylates the p65 subunit of NF-kappaB. The lower affinity of RSK1-phosphorylated p65 for its negative regulator, IkappaBalpha, decreases IkappaBalpha-mediated nuclear export of shuttling forms of NF-kappaB, thereby promoting the binding and action of NF-kappaB on cognate kappaB enhancers. These findings highlight a rather unusual pathway of NF-kappaB activation, which is utilized by the p53 tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073170     DOI: 10.1074/jbc.M313509200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

1.  Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Anisha Chinthalapally; Pomila Singh; Shanjana Awasthi; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

3.  Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells.

Authors:  Rina Gendelman; Heming Xing; Olga K Mirzoeva; Preeti Sarde; Christina Curtis; Heidi S Feiler; Paul McDonagh; Joe W Gray; Iya Khalil; W Michael Korn
Journal:  Cancer Res       Date:  2017-01-13       Impact factor: 12.701

4.  Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation.

Authors:  Yu Wang; Guang-Sheng Xiang; Famourou Kourouma; Shahid Umar
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

5.  Induction of monocyte chemotactic protein 1 in colonic epithelial cells by Entamoeba histolytica is mediated via the phosphatidylinositol 3-kinase/p65 pathway.

Authors:  Srinivas J Kammanadiminti; Indranil Dey; Kris Chadee
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

6.  Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors.

Authors:  Yun Dai; Shuang Chen; Li Wang; Xin-Yan Pei; Vanessa L Funk; Lora B Kramer; Paul Dent; Steven Grant
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 7.  Specification of DNA binding activity of NF-kappaB proteins.

Authors:  Fengyi Wan; Michael J Lenardo
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

8.  Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.

Authors:  Braden C McFarland; G Kenneth Gray; Susan E Nozell; Suk W Hong; Etty N Benveniste
Journal:  Mol Cancer Res       Date:  2013-02-05       Impact factor: 5.852

9.  Phenolic fraction of tobacco smoke condensate potentiates benzo[a]pyerene diol epoxide-induced cell transformation: role of protein kinase C.

Authors:  Jagat J Mukherjee; Subodh Kumar
Journal:  Mutat Res       Date:  2009-12-16       Impact factor: 2.433

10.  Phosphorylation of IκBα at serine 32 by T-lymphokine-activated killer cell-originated protein kinase is essential for chemoresistance against doxorubicin in cervical cancer cells.

Authors:  Jung-Hwan Park; Dae-Sung Yoon; Hye-Jin Choi; Dae-Hyun Hahm; Sang-Muk Oh
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.